[go: up one dir, main page]

DK155690D0 - NEW PEPTIDES - Google Patents

NEW PEPTIDES

Info

Publication number
DK155690D0
DK155690D0 DK155690A DK155690A DK155690D0 DK 155690 D0 DK155690 D0 DK 155690D0 DK 155690 A DK155690 A DK 155690A DK 155690 A DK155690 A DK 155690A DK 155690 D0 DK155690 D0 DK 155690D0
Authority
DK
Denmark
Prior art keywords
new peptides
peptides
new
Prior art date
Application number
DK155690A
Other languages
Danish (da)
Inventor
Jan Markussen
Liselotte Langkjaer
Kjeld Norris
Leo Boye Snel
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK155690A priority Critical patent/DK155690D0/en
Publication of DK155690D0 publication Critical patent/DK155690D0/en
Priority to EP91912264A priority patent/EP0536245A1/en
Priority to PCT/DK1991/000167 priority patent/WO1992000321A1/en
Priority to AU80543/91A priority patent/AU8054391A/en
Priority to JP3511335A priority patent/JPH05508406A/en
Priority to ZA914830A priority patent/ZA914830B/en
Priority to IL98596A priority patent/IL98596A0/en
Priority to NZ238718A priority patent/NZ238718A/en
Priority to PT98124A priority patent/PT98124A/en
Priority to IE224791A priority patent/IE912247A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK155690A 1990-06-28 1990-06-28 NEW PEPTIDES DK155690D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DK155690A DK155690D0 (en) 1990-06-28 1990-06-28 NEW PEPTIDES
EP91912264A EP0536245A1 (en) 1990-06-28 1991-06-21 Novel, protracted insulin analogues
PCT/DK1991/000167 WO1992000321A1 (en) 1990-06-28 1991-06-21 Novel, protracted insulin analogues
AU80543/91A AU8054391A (en) 1990-06-28 1991-06-21 Novel, protracted insulin analogues
JP3511335A JPH05508406A (en) 1990-06-28 1991-06-21 Novel protected insulin analogs
ZA914830A ZA914830B (en) 1990-06-28 1991-06-24 Novel,protracted insulin analogues
IL98596A IL98596A0 (en) 1990-06-28 1991-06-24 Insulin analogues having prolonged action,their preparation and injectable solutions containing them
NZ238718A NZ238718A (en) 1990-06-28 1991-06-26 Insulin analogue and its preparation
PT98124A PT98124A (en) 1990-06-28 1991-06-27 PROCESS FOR THE PREPARATION OF NEW PROLONGED ACID INSULIN ANALOGS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IE224791A IE912247A1 (en) 1990-06-28 1991-06-27 Novel, protracted insulin analogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK155690A DK155690D0 (en) 1990-06-28 1990-06-28 NEW PEPTIDES

Publications (1)

Publication Number Publication Date
DK155690D0 true DK155690D0 (en) 1990-06-28

Family

ID=8106031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK155690A DK155690D0 (en) 1990-06-28 1990-06-28 NEW PEPTIDES

Country Status (10)

Country Link
EP (1) EP0536245A1 (en)
JP (1) JPH05508406A (en)
AU (1) AU8054391A (en)
DK (1) DK155690D0 (en)
IE (1) IE912247A1 (en)
IL (1) IL98596A0 (en)
NZ (1) NZ238718A (en)
PT (1) PT98124A (en)
WO (1) WO1992000321A1 (en)
ZA (1) ZA914830B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109646396A (en) * 2018-12-29 2019-04-19 江苏万邦医药科技有限公司 A kind of stable insulin analog injection and preparation method thereof

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU217684B (en) * 1993-09-17 2000-03-28 Novo Nordisk A/S Acylated insulin derivatives and pharmaceutical compositions containing them and their preparation
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
US6251856B1 (en) 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
HUP9800523A3 (en) * 1995-03-17 1998-09-28 Novo Nordisk As Insulin derivatives
DE19726167B4 (en) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, process for its preparation and pharmaceutical preparation containing it
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
ES2397241T3 (en) 2004-01-21 2013-03-05 Novo Nordisk Health Care Ag Conjugation of peptides by transglutaminase
WO2008015099A2 (en) 2006-07-31 2008-02-07 Novo Nordisk A/S Pegylated, extended insulins
JP5864834B2 (en) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス Protease resistant insulin analogue
ES2563038T3 (en) 2007-04-30 2016-03-10 Novo Nordisk A/S Method for drying a protein composition, a dry protein composition and a pharmaceutical composition comprising the dry protein
EP2229407B1 (en) 2008-01-09 2016-11-16 Sanofi-Aventis Deutschland GmbH Novel insulin derivatives having an extremely delayed time-action profile
CN101970477B (en) 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 Protease-stabilized insulin analogues
JP5749155B2 (en) 2008-03-18 2015-07-15 ノボ・ノルデイスク・エー／エス Protease stabilized acylated insulin analogue
DE102009038210A1 (en) 2009-08-20 2011-03-03 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a GLP-1 agonist
PT2349324T (en) 2008-10-17 2017-12-06 Sanofi Aventis Deutschland Combination of an insulin and a glp-1 agonist
DE102008053048A1 (en) 2008-10-24 2010-04-29 Sanofi-Aventis Deutschland Gmbh Medicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonist
DE102008051834A1 (en) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Drug, useful e.g. for treating diabetes, preferably type-I or II and for controlling fasting, postprandial and/or postabsorptive plasma glucose concentration, comprises insulin and glucagon-like peptide-1 agonist
DE102008064270A1 (en) * 2008-12-20 2010-07-01 Voith Patent Gmbh Flotation method for removing contaminants from aqueous fibrous material suspension by gas bubbles, involves supplying stream of fibrous material suspension along interference body after supplying stream of gas
CN105535943A (en) 2009-07-06 2016-05-04 赛诺菲-安万特德国有限公司 Aqueous insulin preparations containing methionine
WO2011003823A1 (en) 2009-07-06 2011-01-13 Sanofi-Aventis Deutschland Gmbh Slow-acting insulin preparations
US20120241356A1 (en) 2009-07-06 2012-09-27 Sanofi-Aventis Deutschland Gmbh Heat- and vibration-stable insulin preparations
UA108475C2 (en) 2009-07-31 2015-05-12 Санофі-Авентіс Дойчланд Гмбх Long-acting insulin composition
PE20120918A1 (en) 2009-07-31 2012-08-14 Sanofi Aventis Deutschland DEPTH DRUGS THAT INCLUDE AN INSULIN-CONNECTOR CONJUGATE
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
WO2011058083A1 (en) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
EP2585484A1 (en) * 2010-06-23 2013-05-01 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
CN104693302A (en) * 2010-06-23 2015-06-10 诺沃—诺迪斯克有限公司 Insulin derivatives containing additional disulfide bonds
EP2585483A1 (en) * 2010-06-23 2013-05-01 Novo Nordisk A/S Human insulin containing additional disulfide bonds
RS55378B1 (en) 2010-08-30 2017-03-31 Sanofi Aventis Deutschland USE OF AVE0010 FOR MANUFACTURE OF TREATMENT OF DIABETES MELLITUS TYPE 2
EP2438930A1 (en) 2010-09-17 2012-04-11 Sanofi-Aventis Deutschland GmbH Prodrugs comprising an exendin linker conjugate
JP2014509603A (en) 2011-03-15 2014-04-21 ノヴォ ノルディスク アー／エス Human insulin analogues and human insulin derivatives containing cysteine substitutions
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
HRP20151068T1 (en) 2011-08-29 2016-01-01 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
AR087744A1 (en) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
BR112014025132A2 (en) 2012-04-11 2017-07-11 Novo Nordisk As insulin formulations
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
PT2854841T (en) 2012-06-04 2017-05-15 Diamedica Inc Human tissue kallikrein 1 glycosylation isoforms
CA2889165A1 (en) 2012-12-19 2014-06-26 Wockhardt Limited A stable aqueous composition comprising human insulin or an analogue or derivative thereof
WO2014102623A1 (en) 2012-12-26 2014-07-03 Wockhardt Limited Pharmaceutical composition
TWI641381B (en) 2013-02-04 2018-11-21 法商賽諾菲公司 Stabilized pharmaceutical formulations of insulin analogs and/or insulin derivatives
JP2016531847A (en) 2013-09-30 2016-10-13 ウォックハート リミテッド Pharmaceutical composition
ES2676065T3 (en) 2013-10-07 2018-07-16 Novo Nordisk A/S New derivative of an insulin analog
RU2016132340A (en) 2014-01-09 2018-02-14 Санофи STABILIZED PHARMACEUTICAL COMPOSITIONS BASED ON INSULIN ASPART
SG11201604708VA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604710XA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
WO2016001862A1 (en) 2014-07-04 2016-01-07 Wockhardt Limited Extended release formulations of insulins
TWI758239B (en) 2014-12-12 2022-03-21 德商賽諾菲阿凡提斯德意志有限公司 Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients
HUE060149T2 (en) 2016-12-16 2023-02-28 Novo Nordisk As Insulin containing pharmaceutical compositions
AU2018230478B2 (en) 2017-03-09 2025-01-23 Diamedica Inc. Dosage forms of tissue kallikrein 1
MX2020001434A (en) 2017-08-17 2020-03-20 Novo Nordisk As Novel acylated insulin analogues and uses thereof.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2536040A1 (en) * 1975-08-13 1977-02-24 Hoechst Ag Prolonged action insulin analogues - with A1-glycine replaced by D-alanine or D-serine
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (en) * 1988-05-11 1988-05-11 Novo Industri As NEW PEPTIDES
JPH04502465A (en) * 1988-12-23 1992-05-07 ノボ　ノルディスク　アクティーゼルスカブ human insulin analogue

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109646396A (en) * 2018-12-29 2019-04-19 江苏万邦医药科技有限公司 A kind of stable insulin analog injection and preparation method thereof

Also Published As

Publication number Publication date
EP0536245A1 (en) 1993-04-14
JPH05508406A (en) 1993-11-25
AU8054391A (en) 1992-01-23
IL98596A0 (en) 1992-07-15
PT98124A (en) 1992-04-30
ZA914830B (en) 1992-03-25
WO1992000321A1 (en) 1992-01-09
IE912247A1 (en) 1992-01-01
NZ238718A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
DK155690D0 (en) NEW PEPTIDES
DK257988D0 (en) NEW PEPTIDES
NO972494L (en) Novel hedgehog-derived polypeptides
NO940669D0 (en) Novel isosteric peptides
FI912086A7 (en) Polypeptides
NO942066D0 (en) peptide
NO950852D0 (en) New connections
DK111489D0 (en) PEPTIDES
NO952650D0 (en) New peptides
NO930156D0 (en) NEW OKSAZOLYL DERIVATIVES
FI941758L (en) Recombitope peptides
DK158390D0 (en) NEW PEPTIDES
FI905741A7 (en) Peptides
DK616889A (en) NEW ALFA-CYANO-BETA-OXOPROPIONAMIDES
NO922243L (en) NEW CEFEM CONNECTIONS
FI911351A7 (en) New 8-sulfamylmethylene-2-aminotetralins
MA22717A1 (en) HEMOREGULATORY PEPTIDES
NO924900L (en) NEW TIAZOLS
DK186791D0 (en) NEW ENZYMER
NO942051D0 (en) New thiosemicarbazontions
DK67091D0 (en) NEW PEPTIDES
DK66991D0 (en) NEW PEPTIDES
NO940633D0 (en) New connections
DK312488D0 (en) NEW PEPTIDES
DK245190D0 (en) NEW CONNECTIONS

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed